COVID-19 drug doesn't benefit patients with mild illness, study finds

Ivermectin, a drug that is typically used to treat parasitic worms but has been used widely against COVID-19, doesn't speed recovery of patients with mild cases of the disease, a study published March 4 in JAMA found.